Crown Reserve Acquisition CORP I

Crown Reserve Acquisition Corp. I (CRAC) announced a definitive business combination agreement with Carvix, Inc., a Delaware corporation.

Crown Reserve Acquisition Corp. I announced that its units will begin separate trading of Class A ordinary shares, warrants, and rights on Nasdaq starting December 9, 2025.

Crown Reserve Acquisition Corp. I successfully closed its initial public offering, raising $172.5 million including the full exercise of the underwriters' over-allotment option.

Crown Reserve Acquisition Corp. I, a SPAC, successfully closed its Initial Public Offering and private placement, raising $172.5 million for its trust account to pursue a business combination.

Crown Reserve Acquisition Corp. I successfully completed its Initial Public Offering, raising $172.5 million for future business combinations.

Crown Reserve Acquisition Corp. I, a SPAC, reported a net income of $1.13 million for 2025, primarily from trust account dividends, as it continues its search for a business combination.

Crown Reserve Acquisition Corp. I (SPAC) announced a definitive business combination agreement with Carvix, Inc., aiming for a Delaware domestication and subsequent merger.

Crown Reserve Acquisition Corp. I, a blank check company, filed an S-1/A registration statement for its initial public offering of 15 million units at $10.00 each, aiming to raise $150 million for a business combination.

Crown Reserve Acquisition Corp. I, a blank check company, filed an S-1/A for its initial public offering of 15 million units at $10.00 each, aiming to raise $150 million for a business combination.

Crown Reserve Acquisition Corp. I, a blank check company, filed an S-1/A for its initial public offering of 15 million units at $10.00 each, aiming to raise $150 million for a business combination.

Crown Reserve Acquisition Corp. I, a Cayman Islands-exempted blank check company, filed an amended registration statement for its initial public offering of 15 million units at $10.00 each, aiming to raise $150 million for a business combination with a focus on pharma, medical technology, and healthcare IT industries.

Crown Reserve Acquisition Corp. I, a newly formed blank check company, filed an S-1/A registration statement for its initial public offering of $150 million, aiming to acquire a business primarily in the pharma, medical technology, or healthcare IT industries.

Crown Reserve Acquisition Corp. I, a blank check company, filed an amended S-1 registration statement for its initial public offering of 15,000,000 units at $10.00 per unit, aiming to raise $150 million for a business combination primarily in the pharma, medical technology, medical equipment, and healthcare IT industries.

Westchester Capital Management, LLC and Westchester Capital Partners, LLC have jointly filed a Schedule 13G, reporting beneficial ownership of 5.09% of Crown Reserve Acquisition Corp. I's Class A ordinary shares.

Magnetar Financial LLC and its affiliates have reported a beneficial ownership of 8.60% in Crown Reserve Acquisition Corp. I's Class A ordinary shares as of December 31, 2025.

Harraden Circle investment entities and Frederick V. Fortmiller, Jr. have filed an amended Schedule 13G, indicating they no longer beneficially own more than 5% of Crown Reserve Acquisition Corp. I's Class A Common Stock.

Barclays PLC has reported a beneficial ownership of 6.52% in Crown Reserve Acquisition Corp. Class A common stock as of December 31, 2025.

Feis Equities LLC and Lawrence M. Feis reported a 3.67% passive ownership stake in Crown Reserve Acquisition Corp. I as of January 20, 2026.

Feis Equities LLC and Lawrence M. Feis have reported a beneficial ownership of 5.87% of Crown Reserve Acquisition Corp. I's Class A ordinary shares.